Compare JACK & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JACK | EBS |
|---|---|---|
| Founded | 1951 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.6M | 312.8M |
| IPO Year | 1994 | 2006 |
| Metric | JACK | EBS |
|---|---|---|
| Price | $12.21 | $6.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 3 |
| Target Price | ★ $19.83 | $11.00 |
| AVG Volume (30 Days) | 478.4K | ★ 1.0M |
| Earning Date | 11-18-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | ★ 1.44 | N/A |
| Revenue | ★ $1,465,314,000.00 | $742,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.94 | $7.03 |
| P/E Ratio | $8.79 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.92 | $4.36 |
| 52 Week High | $23.86 | $14.06 |
| Indicator | JACK | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 39.80 | 46.27 |
| Support Level | $11.92 | $6.24 |
| Resistance Level | $14.02 | $6.83 |
| Average True Range (ATR) | 0.61 | 0.41 |
| MACD | 0.07 | -0.04 |
| Stochastic Oscillator | 29.91 | 21.31 |
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America. Its core business includes the Jack in the Box hamburger chain, known for a broad menu that features hamburgers, tacos, sandwiches, salads, and breakfast items. The company also operates the Del Taco brand, which offers a variety of both Mexican and American favorites such as burritos and fries. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.